Legal & General Group PLC Lexicon Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 111,403 shares of LXRX stock, worth $79,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,403

Previous 111,403 -0.0%

Holding current value

$79,096

Previous $174,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.51 - $2.39 $150,904 - $238,849	99,937 Added 871.59%	111,403 $174,000
Q2 2024 Aug 14, 2024	BUY	$1.54 - $2.28 $5,011 - $7,419	3,254 Added 39.62%	11,466 $19,000
Q1 2024 May 14, 2024	SELL	$1.3 - $3.58 $3,829 - $10,546	-2,946 Reduced 26.4%	8,212 $19,000
Q4 2023 Feb 15, 2024	SELL	$1.0 - $1.53 $72,477 - $110,889	-72,477 Reduced 86.66%	11,158 $17,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $2.33 $21,142 - $46,474	-19,946 Reduced 19.26%	83,635 $91,000
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $158,078 - $256,602	73,525 Added 244.63%	103,581 $237,000
Q1 2023 May 15, 2023	BUY	$1.99 - $2.68 $6,771 - $9,120	3,403 Added 12.77%	30,056 $73,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $15,141 - $26,771	7,805 Added 41.41%	26,653 $64,000
Q2 2022 Aug 22, 2022	BUY	$1.31 - $2.69 $1,679 - $3,448	1,282 Added 7.3%	18,848 $35,000
Q3 2021 Nov 15, 2021	BUY	$3.38 - $5.35 $38,572 - $61,054	11,412 Added 185.44%	17,566 $84,000
Q2 2021 Aug 12, 2021	BUY	$4.12 - $5.87 $2,867 - $4,085	696 Added 12.75%	6,154 $28,000
Q1 2021 May 17, 2021	BUY	$3.45 - $9.09 $1,438 - $3,790	417 Added 8.27%	5,458 $32,000
Q3 2020 Nov 13, 2020	SELL	$1.44 - $2.1 $2,717 - $3,962	-1,887 Reduced 27.24%	5,041 $7,000
Q2 2020 Aug 14, 2020	SELL	$1.75 - $2.3 $813 - $1,069	-465 Reduced 6.29%	6,928 $14,000
Q1 2020 May 14, 2020	SELL	$1.8 - $4.28 $17,319 - $41,182	-9,622 Reduced 56.55%	7,393 $15,000
Q4 2019 Feb 13, 2020	BUY	$3.16 - $5.15 $4,645 - $7,570	1,470 Added 9.46%	17,015 $71,000
Q4 2018 Feb 15, 2019	BUY	$6.15 - $10.51 $5,319 - $9,091	865 Added 5.89%	15,545 $103,000
Q2 2018 Aug 10, 2018	SELL	$7.8 - $13.69 $9,430 - $16,551	-1,209 Reduced 7.61%	14,680 $176,000
Q1 2018 May 17, 2018	SELL	$7.86 - $11.39 $29,946 - $43,395	-3,810 Reduced 19.34%	15,889 $136,000
Q4 2017 Feb 13, 2018	BUY	$8.77 - $12.28 $172,760 - $241,903	19,699	19,699 $197,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $134M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Lexicon Pharmaceuticals, Inc. Transaction History